First Patient Enrolled in Phase 3 Trial of Firdapse in MuSK Antibody Positive Myasthenia Gravis
April 19th 2018The first patient was enrolled in a Phase 3 clinical trial of amifampridine phosphate (Firdapse) in patients with mmuscle-specific kinase (MuSK) antibody positive myasthenia gravis (MuSK-MG).
Read More